Boehringer Ingelheim Invests More Than 200 Million to Establish Strateg
With this new site, the company will be able to respond to the growing globa...
2018-07-11
文传商讯
CHMP issues positive opinion to expand Jardiance, Synjardy and Glyxambi
European labels for Jardiance, Synjardy and Glyxambi expanded to include pos...
2018-07-03
文传商讯
World Scleroderma Day 2018: Families open up about supporting a loved o
Boehringer Ingelheim provides platform to families and loved ones of people ...
2018-07-02
文传商讯
Boehringer Ingelheim R&D Pushes to Transcend Disease Boundaries
Promising first-in-class and potential medical breakthrough pipeline project...
2018-04-28
文传商讯
Boehringer Ingelheim and Lilly Announce an Academic Collaboration with
University of Oxford to assess effect of empagliflozin on heart and kidney d...
2018-04-17
文传商讯
Three Leading Animal Health Companies Join Hands to Launch World-Class
Boehringer Ingelheim, KMOH, and ZNWT establish a vaccine joint venture targe...
2018-03-28
文传商讯
FDA grants Fast Track designation to nintedanib for the treatment of sy
Fast Track designation facilitates development of new therapies that treat s...
2018-03-21
文传商讯
Boehringer Ingelheim Starts New Campaign: ‘Why wait in IPF?’
Rare Disease Day draws attention to the importance of early diagnosis and tr...
2018-03-01
文传商讯
Systemic Sclerosis World Congress: Inspirational Patient Stories Reveal
'More Than Scleroderma: The Inside Story' provides real-life stories...
2018-02-25
文传商讯
Faslodex (Fulvestrant) Receives EU Approval for the Treatment of Hormon
First EU approval for fulvestrant in combination with a CDK4/6 inhibitor Fu...
2017-11-17
文传商讯
